Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Viavi Solutions Inc. closed its acquisition of Spirent’s high-speed ethernet, network security and channel emulation testing business from Keysight. To fund a portion of the deal and related costs, Viavi entered a new $600 million senior secured term loan maturing on October 16, 2032, borrowed in full at closing and secured by substantially all assets of Viavi and certain domestic subsidiaries.
The loan bears interest at Term SOFR + 2.50%/2.25% or a base rate + 1.50%/1.25%, depending on a first lien leverage ratio threshold of 0.90 to 1.00. Principal amortizes 1% per year in quarterly payments starting March 31, 2026, with a 1% prepayment premium on certain repricings within six months. Mandatory prepayments apply upon specified asset sales, excess cash flow and unpermitted debt.
Viavi also amended its revolving credit facility, reducing capacity from $300 million to $200 million and extending maturity to the earlier of October 16, 2030 or a springing date tied to existing notes.
VIAVI Solutions Inc. reporting person Paul McNab, EVP, Chief Marketing & Strategy Officer, filed a Form 4 disclosing an insider disposition of common stock on 10/01/2025. The filing reports a disposition of 5,509 shares under transaction code G(1) as an exempt transfer at no cash price, leaving 63,265 shares beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on 10/08/2025. The filing indicates the report was made by one reporting person and identifies the filer as both an officer and director.
VIAVI Solutions presents its DEF 14A proxy disclosures describing board composition, governance practices, executive pay philosophy, equity plans and committee oversight. Stockholders approved the company’s executive compensation program with 94% of votes cast in favor at the 2024 annual meeting. The Board reports 9 of 10 directors are independent, held 10 meetings in FY25, and each director attended at least 75% of meetings. The company states its stock price rose 45.6% in FY25 and that the CEO’s realizable value for FY25 awards was about 100.3% of target. PwC was reappointed as independent auditor and the Audit Committee recommends ratification. The proxy discloses an amended equity incentive plan, officer exculpation amendment proposed for stockholder vote, director nominations (including additions in July 2025), and 222,655,443 shares outstanding as of August 31, 2025.
VIAVI Solutions director Richard Belluzzo reported a sale of company stock under a pre-established trading plan. On 10/01/2025 Mr. Belluzzo disposed of 8,387 shares of VIAV common stock under a Rule 10b5-1 trading plan dated February 4, 2025, at a weighted-average price of $12.63 per share. After the reported sale, he beneficially owns 217,154 shares, which include 83,292 shares held in trust for his family for which he has sole voting and investment power. The Form 4 was filed as a single reporting person filing and signed by an attorney-in-fact.
Form 144 notice for VIAV (VIAVI Solutions Inc.) reports proposed and recent sales of common stock by an insider. The filer lists a proposed sale of 8,387 shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $105,956.33 and an approximate sale date of 10/01/2025. The filing shows the shares were originally acquired as restricted stock on 02/22/2017 (5,937 shares) and 11/15/2019 (2,450 shares). It also records two recent sales by the same person: 8,385 shares on 09/02/2025 for $95,067.45 and 8,385 shares on 08/01/2025 for $81,500.52. The signer certifies no undisclosed material adverse information.
VIAVI Solutions insider sale under pre-set plan. Luke M. Scrivanich, SVP General Manager OSP, reported the sale of 8,987 shares of VIAV common stock on 09/25/2025 at a weighted average price of $12.17 per share. The filing states the shares were sold pursuant to a Rule 10b5-1 trading plan established on September 11, 2024. After the reported transactions Mr. Scrivanich beneficially owns 79,335 shares, held directly. The filing includes an offer to provide detailed trade-by-trade prices and quantities upon request.
Kevin Christopher Siebert, SVP General Counsel & Secretary of VIAVI Solutions Inc. (VIAV), reported a sale of 9,927 shares of the issuer's common stock on 09/25/2025. The sale was made pursuant to a Rule 10b5-1 stock trading plan dated September 10, 2024, and was executed in multiple trades at prices ranging from $12.08 to $12.27, with a weighted average sale price of $12.17. Following the reported transaction, the reporting person beneficially owned 84,598 shares. The Form 4 was signed by attorney-in-fact Donna T. Rossi.
Form 144 notice for VIAV (Viavi Solutions Inc.) reporting proposed sale of company common stock. The filing shows 8,987 shares to be sold through Morgan Stanley Smith Barney LLC on 09/25/2025 on NASDAQ with an aggregate market value of $109,369.09. The shares were acquired as performance shares from the issuer on 09/23/2025 and payment is recorded as 09/23/2025. The filer reports 223,245,915 shares outstanding for the class. The notice also discloses that the same account sold 11,873 shares on 08/29/2025 for gross proceeds of $132,693.84. The form includes the standard representation that the seller does not possess undisclosed material adverse information.
VIAVI Solutions (VIAV) filed a Form 144 reporting a proposed sale of 9,927 common shares to be sold through Morgan Stanley Smith Barney on 09/25/2025, with an aggregate market value of $120,809.60. The filer reports total shares outstanding of 223,245,915. The shares were acquired as performance shares from the issuer on 09/23/2025 and payment is recorded as Not Applicable. The filing also discloses a recent sale by Kevin Siebert of 13,115 shares on 08/29/2025 for gross proceeds of $146,560.13. Some filer identification fields (CIK/CCC/contact) are not provided in the text.
Gary W. Staley, SVP Global Sales of VIAVI Solutions Inc. (VIAV), reported equity transactions on 09/23/2025 reflecting the vesting of market‑leveraged stock units (MSUs) and related tax withholdings. Three MSU tranches converted to common stock: 6,604, 13,685, and 28,217 shares were recorded as acquisitions upon vesting. The company withheld 2,599, 5,386, and 11,104 shares, respectively, to satisfy tax obligations. The filing states the tranches vested at 56.67%, 90.33%, and 128.00% of target based on total shareholder return, and notes MSUs have no expiration. Following these transactions, the reporting person beneficially owns 44,092 shares.